Delivery Order SPE2DB22D3501-SPE2DB24FWL60
Award Date
7/30/24
Potential Completion Date
7/31/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,598.50, is for the delivery of Renflexis 100 mg vials, a pharmaceutical product. The contract has an ultimate completion date of April 29, 2025 and is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Renflexis 100 mg vials. The contract has a ceiling value of $1,242.50 and runs through December 12, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,093.08, is for the delivery of Renflexis 100 mg vials. It is a firm fixed-price contract with an ultimate completion date of April 16, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $24,418.02 to supply Renflexis 100 mg vials. The contract has an ultimate completion date of September 27, 2024 and is a firm fixed price contract. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to the U.S. federal government, including military treatment facilities and veterans' healthcare programs. This award...
This is a $18,510.08 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The order is for the pharmaceutical product Renflexis 100 mg vials. The contract has an ultimate completion date of August 22, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been awarded multiple federal contracts to supply a variety of prescription medications, medical supplies, and equipment to support military treatment...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Renflexis 100 mg vials. The contract has a ceiling value of $6,529.60 and runs through November 24, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,602.70 firm-fixed-price delivery order is for the supply of 100 mg vials of the medication Renflexis. The contract has an ultimate completion date of November 8, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg vials of the drug Renflexis. The $5,386.56 firm fixed-price contract has an ultimate completion date of August 28, 2023. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, with a ceiling value of $15,414.23, is for the delivery of Renflexis 100 mg vials, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 12, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp is a for-profit...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $6,231.96, is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The contract has a period of performance through September 11, 2024 and is a firm-fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to...